U.S. Appeals Court Invalidates J&J Patent on Remicade
U.K. Competition Watchdog Accuses Merck of Obstructing Biosimilars
Biosimilars to Raise Unique Questions
Samsung Bioepis Receives Final European Approval for Its Remicade Copy
Roche & Novartis Face Off in Biosimilar Drug Battle
